{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T09:06:01Z","timestamp":1777799161565,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.canep.2017.07.001","type":"journal-article","created":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T05:02:39Z","timestamp":1499922159000},"page":"186-194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Survival after recurrence of stage I\u2013III breast, colorectal, or lung cancer"],"prefix":"10.1016","volume":"49","author":[{"given":"Michael J.","family":"Hassett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Uno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel M.","family":"Cronin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikki M.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark C.","family":"Hornbrook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Fishman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra P.","family":"Ritzwoller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.canep.2017.07.001_bib0005","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1200\/JCO.2008.19.8424","article-title":"Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer","volume":"27","author":"Anderson","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"13","key":"10.1016\/j.canep.2017.07.001_bib0010","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1200\/JCO.2005.04.3273","article-title":"Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials","volume":"24","author":"Wapnir","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.canep.2017.07.001_bib0015","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1097\/JTO.0000000000000689","volume":"10","author":"Lee","year":"2015","journal-title":"J. Thorac. Oncol."},{"issue":"7","key":"10.1016\/j.canep.2017.07.001_bib0020","first-page":"496","article-title":"[Retrospective analysis of 856 cases with stage 0 to III rectal cancer underwent curative surgery combined modality therapy]","volume":"53","author":"Chen","year":"2015","journal-title":"Zhonghua wai ke za zhi [Chin. J. Surg.]"},{"issue":"2","key":"10.1016\/j.canep.2017.07.001_bib0025","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4048\/jbc.2015.18.2.160","article-title":"Risk factors associated with distant metastasis and survival outcomes in Breast cancer patients with locoregional recurrence","volume":"18","author":"Park","year":"2015","journal-title":"J. Breast Cancer"},{"issue":"12","key":"10.1016\/j.canep.2017.07.001_bib0030","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1007\/s00384-015-2356-x","article-title":"Intensive surveillance following curative treatment of colorectal cancer allows effective treatment of recurrence even if limited to 4 years","volume":"30","author":"Adams","year":"2015","journal-title":"Int. J. Colorectal Dis."},{"issue":"4","key":"10.1016\/j.canep.2017.07.001_bib0035","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s00520-015-2931-2","article-title":"Effects of adjuvant chemotherapy on recurrence, survival, and quality of life in stage II colon cancer patients: a 24-month follow-up","volume":"24","author":"Lewis","year":"2015","journal-title":"Supportive Care Cancer"},{"issue":"2","key":"10.1016\/j.canep.2017.07.001_bib0040","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10549-015-3533-x","article-title":"Recurrence and survival among breast cancer patients achieving a pathological complete response to neoadjuvant chemotherapy","volume":"153","author":"Chaudry","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.canep.2017.07.001_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clbc.2014.05.005","article-title":"Inflammatory breast cancer management in the national comprehensive cancer network: the disease, recurrence pattern, and outcome","volume":"15","author":"Matro","year":"2015","journal-title":"Clin. Breast Cancer"},{"issue":"20","key":"10.1016\/j.canep.2017.07.001_bib0050","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1200\/JCO.2014.57.1349","article-title":"Racial and ethnic differences in breast cancer survival: mediating effect of tumor characteristics and sociodemographic and treatment factors","volume":"33","author":"Warner","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canep.2017.07.001_bib0055","doi-asserted-by":"crossref","unstructured":"J.Z. Ayanian, E.A. Chrischilles, R.H. Fletcher, M.N. Fouad, D.P. Harrington, K.L. Kahn, C.I. Kiefe, J. Lipscomb, J.L. Malin, A.L. Potosky, et al. Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium.[see comment][erratum appears in J Clin Oncol. 2004 Dec 15;22(24):5026]. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2004, 22(15):2992-2996.","DOI":"10.1200\/JCO.2004.06.020"},{"issue":"2","key":"10.1016\/j.canep.2017.07.001_bib0060","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1097\/MLR.0b013e318222a711","article-title":"Cancer care outcomes research surveillance C: representativeness of participants in the cancer care outcomes research and surveillance consortium relative to the surveillance, epidemiology, and end results program","volume":"51","author":"Catalano","year":"2013","journal-title":"Med. Care"},{"issue":"10","key":"10.1016\/j.canep.2017.07.001_bib0065","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1097\/MLR.0b013e318277eb6f","article-title":"Validating billing\/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts","volume":"52","author":"Hassett","year":"2014","journal-title":"Med. Care"},{"issue":"10","key":"10.1016\/j.canep.2017.07.001_bib0070","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1097\/MLR.0b013e31824def85","article-title":"Validation of electronic data on chemotherapy and hormone therapy use in HMOs","volume":"51","author":"Ritzwoller","year":"2013","journal-title":"Med. Care"},{"issue":"1","key":"10.1016\/j.canep.2017.07.001_bib0075","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00005650-199601000-00006","article-title":"Can comorbidity be measured by questionnaire rather than medical record review?","volume":"34","author":"Katz","year":"1996","journal-title":"Med. Care"},{"issue":"12","key":"10.1016\/j.canep.2017.07.001_bib0080","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0895-4356(00)00256-0","article-title":"Development of a comorbidity index using physician claims data","volume":"53","author":"Klabunde","year":"2000","journal-title":"J. Clin. Epidemiol."},{"issue":"5","key":"10.1016\/j.canep.2017.07.001_bib0085","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic Dis."},{"issue":"10","key":"10.1016\/j.canep.2017.07.001_bib0090","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1097\/MLR.0b013e31824def85","article-title":"Validation of electronic data on chemotherapy and hormone therapy use in HMOs","volume":"51","author":"Ritzwoller","year":"2013","journal-title":"Med. Care"},{"issue":"15","key":"10.1016\/j.canep.2017.07.001_bib0095","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1200\/JCO.2015.64.2488","article-title":"Comparison of treatment effects measured by the hazard ratio and by the ratio of restricted mean survival times in oncology randomized controlled trials","volume":"34","author":"Trinquart","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"30","key":"10.1016\/j.canep.2017.07.001_bib0100","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1200\/JCO.2007.14.1168","article-title":"Trends in survival over the past two decades among white and black patients with newly diagnosed stage IV breast cancer","volume":"26","author":"Dawood","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canep.2017.07.001_bib0105","first-page":"1","article-title":"Initial surgery and survival in stage IV breast cancer in the United States, 1988\u20132011","author":"Thomas","year":"2015","journal-title":"JAMA Surg."},{"issue":"16","key":"10.1016\/j.canep.2017.07.001_bib0110","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1002\/cncr.28143","article-title":"Changing prognosis of metastatic colorectal adenocarcinoma: differential improvement by age and tumor location","volume":"119","author":"Golan","year":"2013","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.canep.2017.07.001_bib0115","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1200\/JCO.2011.38.9650","article-title":"Effectiveness of bevacizumab with first-line combination chemotherapy for medicare patients with stage IV colorectal cancer","volume":"30","author":"Meyerhardt","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.canep.2017.07.001_bib0120","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1097\/MLR.0b013e31828fad9f","article-title":"Algorithm for identifying chemotherapy\/biological regimens for metastatic colon cancer in SEER-Medicare","volume":"53","author":"Bikov","year":"2015","journal-title":"Med. Care"},{"issue":"4","key":"10.1016\/j.canep.2017.07.001_bib0125","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv002","article-title":"Effect of prior cancer on outcomes in advanced lung cancer: implications for clinical trial eligibility and accrual","volume":"107","author":"Laccetti","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canep.2017.07.001_bib0130","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1186\/s12913-014-0555-8","article-title":"Comparison of demographics, treatment patterns, health care utilization, and costs among elderly patients with extensive-stage small cell and metastatic non-small cell lung cancers","volume":"14","author":"Karve","year":"2014","journal-title":"BMC Health Serv. Res."},{"issue":"5","key":"10.1016\/j.canep.2017.07.001_bib0135","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1634\/theoncologist.2012-0480","article-title":"Real-world effectiveness of systemic agents approved for advanced non-small cell lung cancer: a SEER-Medicare analysis","volume":"18","author":"Owonikoko","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.canep.2017.07.001_bib0140","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2147\/CLEP.S17191","article-title":"Survival by histologic subtype in stage IV nonsmall cell lung cancer based on data from the surveillance, epidemiology and end results program","volume":"3","author":"Cetin","year":"2011","journal-title":"Clin. Epidemiol."},{"issue":"1","key":"10.1016\/j.canep.2017.07.001_bib0145","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/jnci\/dju336","article-title":"Generalizability of trial results to elderly Medicare patients with advanced solid tumors (Alliance 70802)","volume":"107","author":"Lamont","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canep.2017.07.001_bib0150","series-title":"Cancer Facts & Figures 015","author":"Society","year":"2015"},{"key":"10.1016\/j.canep.2017.07.001_bib0155","series-title":"Fast Stats: An Interactive Tool for Access to SEER Cancer Statistics","author":"Program","year":"2015"},{"issue":"18","key":"10.1016\/j.canep.2017.07.001_bib0160","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMp1510443","article-title":"Trends in metastatic Breast and prostate Cancer\u2013Lessons in cancer dynamics","volume":"373","author":"Welch","year":"2015","journal-title":"N. Engl. J. Med."}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782117301005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782117301005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T03:25:36Z","timestamp":1535599536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782117301005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":32,"alternative-id":["S1877782117301005"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2017.07.001","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival after recurrence of stage I\u2013III breast, colorectal, or lung cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2017.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}